New York State Common Retirement Fund Silverback Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 36,342 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,342
Previous 41,703
12.86%
Holding current value
$0
Previous $605,000
36.69%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SBTX
# of Institutions
172Shares Held
65MCall Options Held
842KPut Options Held
589K-
Deerfield Management Company, L.P. (Series C) New York, NY11.1MShares$00.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.29MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY4.08MShares$00.0% of portfolio
-
Sr One Capital Management, LP4.01MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...